Inovio Pharmaceuticals, Inc. Share Price Today: Live Updates & Key Insights
Inovio Pharmaceuticals, Inc. share price today is $1.64, up -4.24%. The stock opened at $1.66 against the previous close of $1.65, with an intraday high of $1.665 and low of $1.58.
Inovio Pharmaceuticals, Inc. Share Price Chart
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Share Price Performance
Inovio Pharmaceuticals, Inc. Institutional Holdings
Inovio Pharmaceuticals, Inc. Market Status
Inovio Pharmaceuticals, Inc. Fundamentals
Market Cap 109.01 M
PB Ratio 4.7246
PE Ratio 0.0
Enterprise Value 64.70 M
Total Assets 74310.04 M
Volume 993944
Inovio Pharmaceuticals, Inc. Company Financials
About Inovio Pharmaceuticals, Inc. & investment objective
Company Information Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade squamous intraepithelial lesions; INO-3112 for the treatment of HPV-related Oropharyngeal squamous cell carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 2/3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. The company's partners and collaborators ApolloBio Corporation, AstraZeneca, Coherus Biosciences, Defense Advanced Research Projects Agency, HIV Vaccines Trial Network, Kaneka Eurogentec, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the University of Pennsylvania, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.
Organisation Biotechnology
Employees 134
Industry Biotechnology
CEO Dr. Jacqueline E. Shea Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Inovio Pharmaceuticals, Inc. FAQs
What is the share price of Inovio Pharmaceuticals, Inc. today?
The current share price of Inovio Pharmaceuticals, Inc. is $1.64.
Can I buy Inovio Pharmaceuticals, Inc. shares in India?
Yes, Indian investors can buy Inovio Pharmaceuticals, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Inovio Pharmaceuticals, Inc. shares in India?
You can easily invest in Inovio Pharmaceuticals, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Inovio Pharmaceuticals, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Inovio Pharmaceuticals, Inc..
Can I buy fractional shares of Inovio Pharmaceuticals, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Inovio Pharmaceuticals, Inc.?
Inovio Pharmaceuticals, Inc. has a market cap of $109.01 M.
In which sector does Inovio Pharmaceuticals, Inc. belong?
Inovio Pharmaceuticals, Inc. operates in the Biotechnology sector.
What documents are required to invest in Inovio Pharmaceuticals, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Inovio Pharmaceuticals, Inc.?
The PE ratio of Inovio Pharmaceuticals, Inc. is N/A and the PB ratio is 4.72.